Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Karuna Pharmaceuticals, Inc.

http://www.karunapharma.com/

Latest From Karuna Pharmaceuticals, Inc.

Asia Deal Watch: CJ Group Continues Spree With Majority Stake Acquisition In Batavia Biosciences

Plus deals involving Zai Lab/Karuna, Zai Lab/Blueprint, Lotus/PharmaMar, Nippon Shinyaku/Dynacure, Alphamab/Ascletis, Aptose/Hanmi, Shanghai Pharmaceuticals/HUYABIO, KoBioLabs/SPH Sine, CURACLE/ Théa Open Innovation, Signet/XtalPi, Curi Bio/NEXEL, CANbridge/Scriptr and Ligand/CRDC.

Tech Transfer Roundup: Academia's Role In De-Risking Novel Science

The Sanford Burnham Prebys institute is driving innovation in areas like neurodegenerative disease and immuno-oncology. Plus the latest tech transfer deals: two in cancer, one in asthma/allergies and another in lipid nanoparticle technology.

Deals StartUps and SMEs

Immunogenex Inc.

Immunogenex's patent applications describe accessory molecules of the TNF family. The young company is working on an {ex vivo} gene therapy that induces disease-causing cells to express modified TNF ligands so that the offending cells will be recognized and killed by cytotoxic T-cells.

BioPharmaceutical
See All

Company Information

  • Other Names / Subsidiaries
    • PureTech Health
UsernamePublicRestriction

Register